Continuous renal replacement therapy for systemic inflammatory response syndrome: Not today

Pediatric Critical Care Medicine

Volumn 11, Issue 6, 2010, Pages 763-764

  Vernon, Donald D ^a   Sherbotie, Joseph R ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

hemofiltration; intensive care; pediatrics; sepsis; systemic inflammatory response syndrome

Indexed keywords

ICOSANOID; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; EDITORIAL; HEMOFILTRATION; INTENSIVE CARE; MULTIPLE ORGAN FAILURE; OXYGENATION; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 78649527597     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181e89091     Document Type: Editorial

References (12)

1. De Vriese AS, Colardyn FA, Philippe JJ, et al: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999; 10:846-853
2. Marshall JC: Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov 2003; 2:391-405
3. Venkataraman R, Subramanian S, Kellum JA: Clinical review: Extracorporeal blood purification in severe sepsis. Crit Care 2003; 7:139-145
4. Kornelisse RF, Hazelzet JA, Savelkoul HF, et al: The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis 1996; 173:1148-1156
5. McMaster P, Shann F: The use of extracorporeal techniques to remove humoral factors in sepsis. Pediatr Crit Care Med 2003; 4:2-7
6. Payen D, Mateo J, Cavaillon JM, et al: Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit Care Med 2009; 37:803-810
7. Honore PM, Jamez J, Wauthier M, et al: Prospective evaluation of short-term, highvolume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000; 28: 3581-3587
8. de Pont AC: Hemofiltration in the early phase of sepsis: friend or foe? Crit Care Med 2009; 37:1125-1126
9. Naran N, Sagy M, Bock KR: Continuous renal replacement therapy results in respiratory and hemodynamic beneficial effects in pediatric patients with severe systemic inflammatory response syndrome and multiorgan system dysfunction. Pediatr Crit Care Med 2010; 11:737-740
10. Fortenberry JD, Paden ML: Extracorporeal therapies in the treatment of sepsis: experience and promise. Semin Pediatr Infect Dis 2006; 17:72-79
11. Boussekey N, Chiche A, Faure K, et al: A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 2008; 34: 1646-1653
12. Joannes-Boyau O, Honore PM, Boer W, et al: Are the synergistic effects of high-volume haemofiltration and enhanced adsorption the missing key in sepsis modulation? Nephrol Dial Transplant 2009; 24:354-357